This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
10
Check minimum number of events None
10
Include endpoints None
10
Remove individuals based on genotype QC
9
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Pseudofolliculitis barbae based on the number of shared cases.
Broader endpoints:
- Other follicular disorders
- Disorders of skin appendages
- Diseases of the skin and subcutaneous tissue
- Propionic acid derivatives
- Anti-inflammatory and antirheumatic products, non-steroids
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 9 | - | 6 |
Unadjusted prevalence (%) | 0.00 | - | 0.00 |
Mean age at first event (years) | 43.00 | - | 44.71 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: L12_PSEUDOFOLBARB – Pseudofolliculitis barbae
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Pseudofolliculitis barbae
↥Endpoint not on priority list, no data to show.